Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bee venom therapy for localized psoriasis
ACTRN12613001028796Phase 4Completed
- Sponsor
- Faculty of Medicine, Suez Canal University
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of Epivac in psoriasis (2 arms), sponsored by Faculty of Medicine, Suez Canal University. Primary endpoint: Therapeutic effect on localized psoriasis by Physician Global Assessment. Started Jul 2012; status: completed.
02
Drugs
Epivac
03
Conditions
psoriasis
Beyond the preview
Go deeper on ACTRN12613001028796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001028796.